Loading...

Psyence Group Inc.

PSYGF•PNK
Healthcare
Drug Manufacturers - General
$0.14
$0.01(9.76%)
U.S. Market opens in NaNh NaNm

Psyence Group Inc. (PSYGF) Stock Overview

Explore Psyence Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2M
P/E Ratio-0.21
EPS (TTM)$-0.74
ROE-14.36%
Fundamental Analysis

AI Price Forecasts

1 Month$0.39
3 Months$0.23
1 Year Target$0.20

PSYGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Psyence Group Inc. (PSYGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.21 and a market capitalization of 2.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
9.76%
5-Day Change
9.76%
1-Month Change
9.76%
3-Month Change
9.76%
6-Month Change
22.02%
Year-to-Date (YTD) Change
9.76%
1-Year Change
28.60%
3-Year Change
-90.18%
5-Year Change
-81.95%
All-Time (Max) Change
-81.95%

Contact Information

https://www.psyence.com
+1 416 477 1708
200 Bay Street, Toronto, ON, M5J 2J1

Company Facts

IPO DateMay 31, 2022
CountryCA
Actively Trading

Frequently Asked Questions